Robert Bosch Venture Capital has returned for a $13.5m round that came four years after the diagnostic technology developer's series B.

Germany-based molecular diagnostics technology developer GNA Biosolutions has completed a $13.5m series C round backed by industrial product manufacturer Robert Bosch’s corporate venturing arm, Robert Bosch Venture Capital (RBVC). The round included GreyBird Ventures, Occident, Wachstumsfonds Bayern, SHS Gesellschaft für Beteiligungsmanagement, UVC Partners, Mey Capital Matrix, KfW and Btov Partners, while Greybird partner Tom Miller has been appointed chairman…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.